Varian Medical Systems Inc. (VAR): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Varian Medical Systems ( VAR) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.5%. By the end of trading, Varian Medical Systems fell 96 cents (-1.3%) to $72.72 on average volume. Throughout the day, 1.1 million shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 964,500 shares. The stock ranged in price between $72.60-$73.87 after having opened the day at $73.68 as compared to the previous trading day's close of $73.68. Other companies within the Health Services industry that declined today were: Accuray ( ARAY), down 20.2%, MGC Diagnostics ( MGCD), down 10.2%, CombiMatrix Corporation ( CBMX), down 7%, and Misonix ( MSON), down 6.8%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.91 billion and is part of the health care sector. The company has a P/E ratio of 19.3, above the S&P 500 P/E ratio of 17.7. Shares are up 3.2% year to date as of the close of trading on Thursday. Currently there are nine analysts that rate Varian Medical Systems a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, Edap TMS ( EDAP), up 10.6%, Medical Action Industries ( MDCI), up 8%, TearLab Corpoartion ( TEAR), up 7.8%, and Hooper Holmes ( HH), up 6.5%, were all gainers within the health services industry with Humana ( HUM) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

HOLIDAY SPECIAL: Let Jim Cramer show you every trade he is making in his $2.5 Million portfolio. Join now for 14-days FREE. Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

PerkinElmer Takes Cautious Approach to M&A

Here's How Health-Care Reform Will Affect This Cancer Care Company

Corporate Tax Reform Could Be a Bigger Deal for This Company Than the ACA

Here Are the Biotech Stocks Moving Ahead of the Opening Bell

PerkinElmer Medical Imaging Unit Sale Could Be in the Works